USPTO serial 99593876
GLENMERE PHARMS
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- KOLODNER, LOUIS FRANCIS
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with GLENMERE PHARMS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stefan Knirr
1 Northside PiersBrooklyn, NY 11249United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Educational services namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; instruction and training services, in the field of pharmaceutical product development of medicines and cancer treatments; education services relating to medicine, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; organising and conducting seminars and conventions in the field of medicine; information, advisory and consultancy services in relation to all of the aforesaid services. | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and design relating thereto; chemical analysis; chemical research; research and development of new products for others; research and development on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; information, advisory and consultancy services in relation to all of the aforesaid services. | ACTIVE | — |
| 044 | Medical services, veterinary services, and medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Pharmaceutical compounding services; Pharmaceutical advisory services, namely, providing pharmaceutical advice; Provision of pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing information in the field of medicine; horticultural services; information, advisory and consultancy services in relation to all of the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sha-Ron Pierre-Kovler
- Other trademarks owned by Sha-Ron Pierre-Kovler
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GLENMERE PHARMS
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 9, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 3, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 14, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 14, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 14, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 14, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 14, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 12, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 6, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 14, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 14, 2026 | NWAP | NEW APPLICATION ENTERED | — |